Mesenchymal stem cells from different sources show distinct therapeutic effects in hyperoxia‐induced bronchopulmonary dysplasia in rats

Mesenchymal stem cells (MSCs) have been shown as an effective medicinal means to treat bronchopulmonary dysplasia (BPD). The widely used MSCs were from Wharton's jelly of umbilical cord (UC‐MSCs) and bone marrow (BM‐MSCs). Amniotic fluid MSCs (AF‐MSCs) may be produced before an individual is bo...

Descripción completa

Detalles Bibliográficos
Autores principales: Xie, Yingjun, Chen, Fei, Jia, Lei, Chen, Rui, Zhang, Victor Wei, Zhong, Xinqi, Wang, Ding
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8419191/
https://www.ncbi.nlm.nih.gov/pubmed/34322990
http://dx.doi.org/10.1111/jcmm.16817

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8419191/
https://www.ncbi.nlm.nih.gov/pubmed/34322990
http://dx.doi.org/10.1111/jcmm.16817

Ejemplares similares